ReviewMedicine2026
A bibliometric review of hotspots and trends in exosome research over the past decade.
Review in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aims to investigate the recent research hotspots and frontiers in the field of exosomes, offering a comprehensive review of advancements in exosome research and elucidating their implications and future directions.
methodsEnglish-language exosome-related literature indexed in the Web of Science Core Collection database from January 1, 2015, to December 31, 2024, was retrieved, and the data were analyzed using CiteSpace and VOSviewer software.
resultsA total of 26,458 articles were included. The annual publication volume showed steady growth before 2022, followed by fluctuations and stabilization after 2022. The most prolific author was Takahiro Ochiya; the institution with the highest output was Shanghai Jiao Tong University; China was the leading country in terms of publications and maintained extensive collaborations with other nations.
conclusionCurrent exosome research primarily focuses on pharmacological effects, drug delivery, and diagnostic applications, attracting global scholarly attention and demonstrating promising development momentum.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.